Published in J Allergy Clin Immunol on March 30, 2012
Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet (2011) 6.36
Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ (2007) 3.02
Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol (2010) 2.55
Formula selection for management of children with cow's milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr (2013) 2.08
Efficacy of a new hypotonic oral rehydration solution containing zinc and prebiotics in the treatment of childhood acute diarrhea: a randomized controlled trial. J Pediatr (2010) 2.03
Effect of Lactobacillus GG on tolerance acquisition in infants with cow's milk allergy: a randomized trial. J Allergy Clin Immunol (2011) 1.97
Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol (2005) 1.80
An Italian prospective multicenter survey on patients suspected of having non-celiac gluten sensitivity. BMC Med (2014) 1.65
Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Dig Liver Dis (2011) 1.59
Zinc supplementation reduces morbidity and mortality in very-low-birth-weight preterm neonates: a hospital-based randomized, placebo-controlled trial in an industrialized country. Am J Clin Nutr (2013) 1.53
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children. Pediatrics (2006) 1.51
Paediatric conferences: only a profit making enterprise? Acta Paediatr (2012) 1.41
In vitro-deranged intestinal immune response to gliadin in type 1 diabetes. Diabetes (2004) 1.41
Adherence to recommendations for primary prevention of atopic disease in neonatology clinical practice. Pediatr Allergy Immunol (2010) 1.39
The epigenetic effects of butyrate: potential therapeutic implications for clinical practice. Clin Epigenetics (2012) 1.26
Diagnosis and Rationale for Action Against Cow's Milk Allergy (DRACMA): a summary report. J Allergy Clin Immunol (2010) 1.24
Combined use of noninvasive tests is useful in the initial diagnostic approach to a child with suspected inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2006) 1.20
Celiac disease in type 1 diabetes mellitus. Ital J Pediatr (2012) 1.19
Congenital diarrheal disorders: improved understanding of gene defects is leading to advances in intestinal physiology and clinical management. J Pediatr Gastroenterol Nutr (2010) 1.16
HLA related genetic risk for coeliac disease. Gut (2007) 1.16
Gliadin activates HLA class I-restricted CD8+ T cells in celiac disease intestinal mucosa and induces the enterocyte apoptosis. Gastroenterology (2008) 1.15
Evidence for the role of interferon-alfa production by dendritic cells in the Th1 response in celiac disease. Gastroenterology (2007) 1.14
Intestinal T cell responses to gluten peptides are largely heterogeneous: implications for a peptide-based therapy in celiac disease. J Immunol (2009) 1.14
Expression and enzymatic activity of small intestinal tissue transglutaminase in celiac disease. Am J Gastroenterol (2003) 1.13
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr (2008) 1.13
Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut (2006) 1.12
Humoral immune response to tissue transglutaminase is related to epithelial cell proliferation in celiac disease. Gastroenterology (2007) 1.08
IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease. Am J Gastroenterol (2011) 1.04
Nuclear factor kappa B is activated in small intestinal mucosa of celiac patients. J Mol Med (Berl) (2003) 1.03
Neonatal onset intestinal failure: an Italian Multicenter Study. J Pediatr (2008) 1.02
Safety for patients with celiac disease of baked goods made of wheat flour hydrolyzed during food processing. Clin Gastroenterol Hepatol (2010) 1.02
Gliadin regulates the NK-dendritic cell cross-talk by HLA-E surface stabilization. J Immunol (2007) 1.02
Adaptive and innate immune responses in celiac disease. Immunol Lett (2005) 1.01
Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol (2006) 1.00
Potential celiac patients: a model of celiac disease pathogenesis. PLoS One (2011) 0.99
Celiac disease association with CD8+ T cell responses: identification of a novel gliadin-derived HLA-A2-restricted epitope. J Immunol (2003) 0.98
Butyrate as an effective treatment of congenital chloride diarrhea. Gastroenterology (2004) 0.98
Congenital diarrheal disorders: an updated diagnostic approach. Int J Mol Sci (2012) 0.96
Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking. PLoS One (2011) 0.96
Gliadin peptide P31-43 localises to endocytic vesicles and interferes with their maturation. PLoS One (2010) 0.96
Immunogenicity of monococcum wheat in celiac patients. Am J Clin Nutr (2012) 0.93
Rotavirus and celiac disease: clues to the pathogenesis and perspectives on prevention. J Pediatr Gastroenterol Nutr (2007) 0.93
Recent progress in congenital diarrheal disorders. Curr Gastroenterol Rep (2011) 0.93
Serum and intestinal celiac disease-associated antibodies in children with celiac disease younger than 2 years of age. J Pediatr Gastroenterol Nutr (2010) 0.92
Gluten Introduction and the Risk of Coeliac Disease: A Position Paper by the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2016) 0.91
Celiac disease: Working Group Report of the First World Congress of Pediatric Gastroenterology, Hepatology, and Nutrition. J Pediatr Gastroenterol Nutr (2002) 0.91
The PreventCD Study design: towards new strategies for the prevention of coeliac disease. Eur J Gastroenterol Hepatol (2010) 0.90
Immunogenicity of two oat varieties, in relation to their safety for celiac patients. Scand J Gastroenterol (2011) 0.90
Latest developments in the pathogenesis and treatment of celiac disease. J Pediatr (2006) 0.89
Markers of potential coeliac disease in patients with Hashimoto's thyroiditis. Eur J Endocrinol (2002) 0.89
The Potential Therapeutic Efficacy of Lactobacillus GG in Children with Food Allergies. Pharmaceuticals (Basel) (2012) 0.89
An undigested gliadin peptide activates innate immunity and proliferative signaling in enterocytes: the role in celiac disease. Am J Clin Nutr (2013) 0.88
Potential celiac disease in type 1 diabetes: a multicenter study. Diabetes Res Clin Pract (2011) 0.88
Constitutive activation of the signal transducer and activator of transcription pathway in celiac disease lesions. Am J Pathol (2003) 0.87
Italian paediatricians' approach to coeliac disease diagnosis. J Pediatr Gastroenterol Nutr (2009) 0.86
Gastric acidity inhibitors and the risk of intestinal infections. Curr Opin Gastroenterol (2010) 0.86
Effects of disease activity on anti-Saccharomyces cerevisiae antibodies: implications for diagnosis and follow-up of children with Crohn's disease. Inflamm Bowel Dis (2004) 0.85
The diagnosis of food allergy in children. Curr Opin Pediatr (2008) 0.85
Celiac anti-tissue transglutaminase antibodies interfere with the uptake of alpha gliadin peptide 31-43 but not of peptide 57-68 by epithelial cells. Biochim Biophys Acta (2010) 0.85
Gut microbiota as potential therapeutic target for the treatment of cow's milk allergy. Nutrients (2013) 0.85
Intranasal administration of a recombinant alpha-gliadin down-regulates the immune response to wheat gliadin in DQ8 transgenic mice. Immunol Lett (2003) 0.84
Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. Diabetes (2009) 0.84
Crenotherapy modulates the expression of proinflammatory cytokines and immunoregulatory peptides in nasal secretions of children with chronic rhinosinusitis. Am J Rhinol Allergy (2012) 0.83
Immunoregulatory pathways are active in the small intestinal mucosa of patients with potential celiac disease. Am J Gastroenterol (2013) 0.83
Correction of gliadin transport within enterocytes through celiac disease serum. Pediatr Res (2011) 0.83
Adjuvant effect of Lactobacillus casei in a mouse model of gluten sensitivity. Immunol Lett (2008) 0.83
Nitric oxide production in rectal dialysate is a marker of disease activity and location in children with inflammatory bowel disease. Am J Gastroenterol (2002) 0.83
Genotype-dependency of butyrate efficacy in children with congenital chloride diarrhea. Orphanet J Rare Dis (2013) 0.82
The optimal diagnostic workup for children with suspected food allergy. Nutrition (2011) 0.82
The nutritional modulation of the evolving intestine. J Clin Gastroenterol (2008) 0.82
Identification of immunodominant epitopes of alpha-gliadin in HLA-DQ8 transgenic mice following oral immunization. J Immunol (2005) 0.82
Enhanced expression of interferon regulatory factor-1 in the mucosa of children with celiac disease. Pediatr Res (2003) 0.82
Functional consequences of NOD2/CARD15 mutations in Crohn disease. J Pediatr Gastroenterol Nutr (2007) 0.81
Chronic diarrhoea in children. Best Pract Res Clin Gastroenterol (2012) 0.81
Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem (2013) 0.81
Bone involvement in clusters of autoimmune diseases: just a complication? Bone (2009) 0.80
Diarrhea in neonatal intensive care unit. World J Gastroenterol (2010) 0.80
T300A variant of autophagy ATG16L1 gene is associated with decreased antigen sampling and processing by dendritic cells in pediatric Crohn's disease. Inflamm Bowel Dis (2013) 0.80
Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. J Immunol (2005) 0.80